Chapter 24
Chapter Overview
Title: Drugs Used to Treat Angina Pectoris
Source: Clayton’s Basic Pharmacology for Nurses, 19th edition
Author: Michelle Willihnganz, MS, RN, CNE
Lesson Objectives
Define Angina Pectoris: Recognize symptoms and assessment data
Assessments: Identify key assessment data to evaluate anginal attacks
Types of Angina: Differentiate between chronic stable angina and unstable angina
Drug Actions and Adverse Effects: Describe drug classifications for angina treatment
Risk Factors and Lifestyle Changes: Discuss management strategies to prevent disease progression, myocardial infarction, and death.
Angina Pectoris
Definition: Chest discomfort due to inadequate oxygen supply to the heart muscle.
Symptoms:
Squeezing sensation, pressure, tightness, choking, burning, heaviness.
May radiate to neck, shoulder, jaw.
Precipitating Factors:
Physical activity, cold exposure, caffeine, smoking, emotional stress, sexual activities, large meals.
Types of Angina Pectoris
Chronic Stable Angina:
Precipitated by stress/exertion; short duration.
Relieved by rest or nitroglycerin.
Cause: Fixed atherosclerotic obstruction.
Unstable Angina:
Unpredictable changes in frequency, duration, and onset.
Cause: Atherosclerosis and thrombus formation.
Variant Angina (Prinzmetal's Angina):
Occurs at rest with characteristic ECG changes.
Cause: Vasospasm of the coronary artery.
Treatment Goals for Angina Pectoris
Prevent myocardial infarction (MI) and death.
Provide pain relief.
Alternatives to Drug Therapy:
Coronary angioplasty, bypass graft surgery.
Patient Education:
Avoid known precipitating factors, reduce risk factors, engage in exercise.
Drug Classes Used to Treat Angina
Nitrates: Primary treatment for angina.
Beta-adrenergic Blocking Agents: Reduce oxygen demand on the heart.
ACE Inhibitors: Promote vasodilation and prevent thrombus formation.
Calcium Channel Blockers: Improve coronary blood flow, reduce peripheral vascular resistance.
Fatty Oxidase Enzyme Inhibitors and Statins: Additional treatment options.
Platelet-active Agents: Prevent clot formation.
Nursing Process for Anginal Therapy
History Taking:
Evaluate history of anginal attacks, precipitating factors, CNS and cardiovascular signs.
Medication History:
Review prescription and OTC medications.
Nutritional Assessment:
Check for history of high cholesterol.
Drug Class: Nitrates
Nitroglycerin:
Main drug for angina treatment.
Actions: Decreases heart's oxygen demand; dilates arteries/veins; lowers blood volume and preload.
Adverse Effects: Hypotension, prolonged headache, tolerance.
Caution: Avoid use with erectile dysfunction drugs (e.g., sildenafil).
Administration Forms for Nitrates
Sublingual Tablets: For acute attacks, dissolve rapidly.
Sustained-Release Tablets/Patches: Used prophylactically.
Transmucosal Tablets/Solutions: For immediate effect.
IV Forms: Used in acute care settings with continuous monitoring.
Sublingual Use for Emergencies
-Instructions:
Patient should sit/lie down, place tablet under tongue without swallowing immediately.
If pain persists after 5 minutes, seek medical attention; may repeat dosing if necessary.
Storage and Maintenance for Sublingual Nitrates
Storage:
Keep in original dark glass container, discard 6 months after opening.
Carrying Nitrates: Always have available but not in direct body heat.
Patient Education for Nitrates
Transdermal Patch: Apply to clean, dry skin, avoid areas with hair or scars, replace if dislodged, avoid tolerance by removing overnight.
Intravenous Administration: Only in acute care settings; requires monitoring, use infusion pumps for accuracy.
Audience Response and Questions
Common Adverse Effects of Sublingual Nitroglycerin: Headache.
Action for Neighbor with Chest Pain: Chew an aspirin tablet after summoning an ambulance.
Reason to Remove Transdermal Patch at Night: To prevent tolerance.
Drug Class to Avoid with Nitrates: Erectile dysfunction drugs.
Core Measure Post-MI: Ensure patients are discharged on Beta-Adrenergic Blockers.
Drug Class: Calcium Channel Blockers
Actions: Inhibit calcium flow across membranes; reduce resistance; improve blood flow.
Uses: Secondary prevention of MI in coronary artery disease.
Drug Class: ACE Inhibitors
Actions: Vasodilation, minimizes platelet aggregation, prevents thrombus.
Uses: Secondary prevention for patients with known coronary artery disease.
Drug Class: Ranolazine (Ranexa)
Action: Modulates metabolism in myocardial cells to reduce oxygen demand.
Common Adverse Effects: Dizziness, headache, constipation, nausea.
Patient Education
Importance of proper medication use and awareness of side effects.
Lifestyle changes: Smoking cessation, recognize and act on chest pain.
Utilize self-assessment forms to monitor condition.
Questions?
Open the floor for questions regarding the content presented.